Brief Context
Context Union Minister Dr. Jitendra Singh said India’s bioeconomy has witnessed a remarkable surge from around $10 billion in 2014 to over $195 billion in 2025, underlining the country’s emergence as a fast-growing global biotechnology hub. What is BioEconomy?
Source Content
Syllabus: GS3/ Economy
Context
- Union Minister Dr. Jitendra Singh said India’s bioeconomy has witnessed a remarkable surge from around $10 billion in 2014 to over $195 billion in 2025, underlining the country’s emergence as a fast-growing global biotechnology hub.
What is BioEconomy?
- The BioEconomy is the knowledge-based production and use of biological resources to provide products, processes and services in all economic sectors within the frame of a sustainable economic system.
- It encompasses sectors like agriculture, forestry, fisheries, food production, biotechnology, and bioenergy.
- Subsectors of the BioEconomy in India are;
- BioPharma or BioMedical: It includes the development and production of medical products and services, such as pharmaceuticals, medical devices, and lab-grown organoids.
- BioAgri: It includes the development and production of genetically modified crops and animals, precision agriculture technologies, and bio-based products. EX: Bt Cotton
- BioIndustrial: It includes the development and production of biobased chemicals and products using enzymes, biosynthetic routes, and recombinant DNA technology.
Growth Trajectory of India’s Bioeconomy
- India’s bioeconomy has expanded nearly 20-fold over a decade, reflecting strong structural growth in the biotechnology sector. India ranks 3rd in the Asia-Pacific region and 12th globally in terms of biomanufacturing.
- It currently contributes around 5% to India’s GDP, indicating its increasing macroeconomic significance.
- Four key subsectors: BioIndustrial (47%), BioPharma (35%), BioAgri (8%), and BioResearch (9%).
Major Government Initiatives
- BioE3 Policy (Biotechnology for Economy, Environment and Employment): Promotes sustainable biomanufacturing and bio-based industries.
- The focus areas include smart proteins, precision therapeutics, and climate-resilient agriculture.
- Research, Development and Innovation (RDI) Fund: ₹1 lakh crore corpus aimed at supporting deep-tech innovation and scaling startups.
- Startup and Incubation Support: Strengthening biotech clusters and innovation hubs across India.
- Inclusive Talent Development: Special focus on tier-2 and tier-3 cities, women entrepreneurs, and young researchers.
Challenges for BioEconomy of India
- Global Competition: India’s BioEconomy faces stiff competition from more established bio Economies in countries like the USA, EU, and China, which have more advanced infrastructure, funding, and R&D capabilities.
- Intellectual Property (IP) Protection: Protecting intellectual property in the biotech sector is challenging, leading to concerns over innovation theft and lack of incentives for research.
- Lack of Infrastructure: Insufficient infrastructure for research, development, and commercialization of biotechnology innovations.
- Brain Drain: Talented scientists and researchers leave India for better opportunities abroad, reducing the country’s capacity for innovation.
Way Ahead
- Strengthening Regulatory Frameworks: Streamlining approval mechanisms while ensuring biosafety and ethical compliance.
- Scaling Deep-Tech Financing: Efficient deployment of the RDI Fund to support high-risk, high-reward innovations.
- Expanding Global Integration: Positioning India as a global hub for biomanufacturing and biotech exports.
- Capacity Building: Investment in advanced skill development, especially in frontier technologies like synthetic biology and bioinformatics.
Source: DD News
Related LearnPro Resources
To revise India’s Bioeconomy Moving Towards $300 billion Target By 2030 in a complete UPSC/JPSC/BPSC preparation flow, use these connected LearnPro resources:
- Daily Current Affairs - follow related daily current affairs updates.
- Daily Editorial - connect this issue with editorial analysis.
- Mains Answer Writing - practice answer writing around this theme.
- PYQ Papers - compare the topic with previous-year questions.
- UPSC Notes - revise the static syllabus background.
India’s Bioeconomy Moving Towards $300 billion Target By 2030 FAQs
What is the main issue in India’s Bioeconomy Moving Towards $300 billion Target By 2030?
India’s Bioeconomy Moving Towards $300 billion Target By 2030 should be understood through its immediate context, legal or policy background, responsible institutions and practical impact on governance. The topic is useful for General Studies because it links a current development with wider administrative and constitutional questions.
Why is India’s Bioeconomy Moving Towards $300 billion Target By 2030 important for UPSC, JPSC and BPSC?
It can help aspirants prepare factual points for Prelims and analytical points for Mains. The issue can be linked with governance, rights, public policy, institutional accountability and state-level implementation depending on the exact syllabus area.
How should aspirants revise this topic?
First revise the facts and institutions mentioned in the article. Then connect the topic with the relevant syllabus heading, prepare 3-4 mains arguments, note one example for answer writing and compare it with related previous-year questions.
What should be avoided while writing an answer on this topic?
Avoid writing only a news summary. A good answer should explain background, causes, implications, challenges, institutional roles and a balanced way forward. Unsupported data and vague generic lines should also be avoided.
How can this topic be linked with state PCS preparation?
State PCS answers can use this topic by adding local governance, district administration, implementation capacity and citizen-service delivery angles, especially for Jharkhand, Bihar and other state-specific examples.
Speak with LearnPro counselling for batch date, mode, syllabus coverage and preparation support.